Results that concluded equol has no effect on breast cancer showed no statistical difference between MCF7 and (±)-equol treatment groups on tumour surface area, cell proliferation (Ki-67 expression), and pS2 mRNA level [39]. The gene discussed is MKI67; the disease is breast carcinoma.